How this supports a project
A PROTAC design must define the target-binding ligand, E3-recruiting ligand, both attachment points, and linker as one testable molecule. Supplying any one component does not establish target degradation.
Design the whole ternary-complex system
A conventional bifunctional PROTAC contains a target-protein ligand, an E3-ligase ligand, and a linker. The attachment point on each ligand is part of the design because it changes how the two proteins and the degrader can form a ternary complex.
Linker selection cannot be reduced to length. Composition, rigidity, polarity, and both exit vectors affect accessible conformations, physicochemical properties, target engagement, and ternary-complex geometry. A linker or E3 ligand that works in one published degrader is therefore a starting point for a new series, not a transferable performance claim.
How material decisions enter the program
Define the target-binding ligand
Provide the exact ligand or reference structure, confirmed binding mode when available, tolerated attachment position, and functional group constraints.
Select the E3-ligase ligand
Identify the E3 system, ligand scaffold, stereochemistry, protected form, and a literature-supported or experimentally justified exit vector.
Plan a linker series
Vary length, PEG or alkyl content, rigidity, polarity, branching, and connection chemistry in a controlled matrix rather than selecting one linker by convention.
Prepare and characterize compounds
Confirm structure, stereochemistry where relevant, identity, purity, residual reagents, solubility handling, and storage conditions for each bifunctional molecule.
Test molecular engagement
Measure target and E3 binding as appropriate and evaluate ternary-complex formation or cooperativity with methods suited to the system.
Confirm degradation mechanism
Establish concentration and time dependence, target loss, proteasome and E3 dependence, selectivity, and functional response with matched controls.
What to define before an inquiry
Target ligand
Exact identity or structure, binding data, attachment position, and groups that must remain unmodified.
E3-ligase system
E3 identity, ligand class, stereochemical requirement, attachment point, and any protected-intermediate preference.
Linker design space
Length range, composition, rigidity, polarity, cleavability if relevant, terminal handles, and acceptable molecular-property limits.
Synthesis plan
Preferred coupling order, protected intermediates, scale, purity target, analytical methods, and material form.
Biological test plan
Cell or biochemical system, target-engagement and degradation assays, time points, controls, and selectivity measurements.
Application boundary
This page covers E3-ligase ligand derivatives, ligand-linker intermediates, PEG or alkyl linkers, reactive handles, and custom bifunctional intermediates. It does not imply target binding, ternary-complex formation, degradation, cellular activity, selectivity, efficacy, safety, clinical suitability, or regulatory status. Those outcomes require testing of the complete molecule in the intended system.
Related catalog and technical pages
Sources
- 1.Catalytic in vivo protein knockdown by small-molecule PROTACs (Nature Chemical Biology, 2015)
- 2.Structural basis of PROTAC cooperative recognition for selective protein degradation (Nature Chemical Biology, 2017)
- 3.E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points (Frontiers in Chemistry, 2021)
- 4.Rationalizing PROTAC-Mediated Ternary Complex Formation Using Rosetta (Journal of Chemical Information and Modeling, 2021)